These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33779002)

  • 1. Ibuprofen enantiomers in premature neonates with patent ductus arteriosus: Preliminary data on an unexpected pharmacokinetic profile of S(+)-ibuprofen.
    Padrini R; Ancora C; Nardo D; De Rosa G; Salvadori S; Bonadies L; Frigo AC; Lago P
    Chirality; 2021 Jun; 33(6):281-291. PubMed ID: 33779002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study.
    Hirt D; Van Overmeire B; Treluyer JM; Langhendries JP; Marguglio A; Eisinger MJ; Schepens P; Urien S
    Br J Clin Pharmacol; 2008 May; 65(5):629-36. PubMed ID: 18307541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the efficacy of ibuprofen and indomethacin in the treatment of patent ductus arteriosus in prematurely born infants].
    Adamska E; Helwich E; Rutkowska M; Zacharska E; Piotrowska A
    Med Wieku Rozwoj; 2005; 9(3 Pt 1):335-54. PubMed ID: 16547381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial.
    Lago P; Bettiol T; Salvadori S; Pitassi I; Vianello A; Chiandetti L; Saia OS
    Eur J Pediatr; 2002 Apr; 161(4):202-7. PubMed ID: 12014386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantiomer specific pharmacokinetics of ibuprofen in preterm neonates with patent ductus arteriosus.
    Engbers AGJ; Flint RB; Völler S; de Klerk JCA; Reiss IKM; Andriessen P; Liem KD; Degraeuwe PLJ; Croubels S; Millecam J; Allegaert K; Simons SHP; Knibbe CAJ
    Br J Clin Pharmacol; 2020 Oct; 86(10):2028-2039. PubMed ID: 32250464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence on renal function of ibuprofen treatment for patent ductus arteriosus in extremely low birthweight infants.
    Nishizaki N; Matsuda A; Yoneyama T; Watanabe A; Obinata K; Shimizu T
    Pediatr Int; 2020 Feb; 62(2):193-199. PubMed ID: 31756017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newborns.
    Flint RB; Ter Heine R; Spaans E; Burger DM; de Klerk JCA; Allegaert K; Knibbe CAJ; Simons SHP
    Eur J Clin Pharmacol; 2018 Dec; 74(12):1585-1591. PubMed ID: 30054639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chiral pharmacokinetics of ibuprofen enantiomers in Chinese preterm neonates with patent ductus arteriosus using a validated UHPLC-MS/MS method.
    Xiao D; Jin Y; Zhang M; Di X; Fu L; Jiang C; Lai Z; Ge Y; Ji S; Zhang Y; Zheng L; Wang Z; Gong F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jul; 1227():123765. PubMed ID: 37454407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method.
    Desfrere L; Zohar S; Morville P; Brunhes A; Chevret S; Pons G; Moriette G; Rey E; Treluyer JM
    J Clin Pharm Ther; 2005 Apr; 30(2):121-32. PubMed ID: 15811164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus.
    Thomas RL; Parker GC; Van Overmeire B; Aranda JV
    Eur J Pediatr; 2005 Mar; 164(3):135-40. PubMed ID: 15717178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and protein binding of intravenous ibuprofen in the premature newborn infant.
    Aranda JV; Varvarigou A; Beharry K; Bansal R; Bardin C; Modanlou H; Papageorgiou A; Chemtob S
    Acta Paediatr; 1997 Mar; 86(3):289-93. PubMed ID: 9099319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Ibuprofen Is More Effective than Intravenous Ibuprofen for Closure of a Patent Ductus Arteriosus: Can Pharmacokinetic Modeling Help Us to Understand Why?
    Smit C; Engbers AGJ; Samiee-Zafarghandy S; van Donge T; Simons SHP; Flint RB; Pfister M; Knibbe CAJ; van den Anker JN
    Neonatology; 2023; 120(1):81-89. PubMed ID: 36502794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is ibuprofen superior to indomethacin for patent ductus arteriosus in Japanese preterm infants?
    Matsumura S; Masutani S; Oshima A; Kanai M; Namba F; Ishiguro A; Kabe K
    Pediatr Int; 2021 Aug; 63(8):929-934. PubMed ID: 33274573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ibuprofen on bilirubin-albumin binding during the treatment of patent ductus arteriosus in preterm infant.
    Thibaut C; Hazard A; Huon C; Desfrere L
    J Matern Fetal Neonatal Med; 2011 Nov; 24 Suppl 3():7-9. PubMed ID: 21815876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetic analysis of Ibuprofen enantiomers in preterm newborn infants.
    Gregoire N; Desfrere L; Roze JC; Kibleur Y; Koehne P
    J Clin Pharmacol; 2008 Dec; 48(12):1460-8. PubMed ID: 18796580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus.
    Van Overmeire B; Touw D; Schepens PJ; Kearns GL; van den Anker JN
    Clin Pharmacol Ther; 2001 Oct; 70(4):336-43. PubMed ID: 11673749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous infusion of ibuprofen for treatment of patent ductus arteriosus in very low birth weight infants.
    Lago P; Salvadori S; Opocher F; Ricato S; Chiandetti L; Frigo AC
    Neonatology; 2014; 105(1):46-54. PubMed ID: 24281435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does ibuprofen treatment in patent ductus arteriosus alter oxygen free radicals in premature infants?
    Akar M; Yildirim TG; Sandal G; Bozdag S; Erdeve O; Altug N; Uras N; Oguz SS; Dilmen U
    Cardiol Young; 2017 Apr; 27(3):507-511. PubMed ID: 27319277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants.
    Varvarigou A; Bardin CL; Beharry K; Chemtob S; Papageorgiou A; Aranda JV
    JAMA; 1996 Feb; 275(7):539-44. PubMed ID: 8606475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing the dose of ibuprofen with postnatal age to close a hemodynamically significant patent ductus arteriosus in very preterm infants.
    Carneiro L; Bouissou A; Favrais G
    Eur J Pediatr; 2023 Aug; 182(8):3527-3535. PubMed ID: 37204599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.